Vebeglogene autotemcel is under clinical development by Lantu Biopharma and currently in Phase II for Beta Thalassaemia.

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

Bryan Johnson, the wealthy tech entrepreneur from Utah at the center of Netflix's new documentary “Don’t Die: The Man Who ...

Hormonal imbalances are frequently implicated in both recurrent miscarriages and infertility. According to Dr Seema Jain, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Gaza’s health ministry said that 88 people had been killed over the past day. Israeli and Hamas officials have been holding indirect cease-fire talks via mediators in Qatar. By Hiba Yazbek and ...

Asia Pacificcategory Head of South Korea Yoon's security finds himself in spotlight January 4, 2025 Asia Pacificcategory South Korea investigators ask acting president to clear way for Yoon's ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Heading into 2025, there are multiple fronts where innovative tech marvels will lead the next evolution of global living as ...

Police yesterday, December 25, arrested a Thai woman and a transwoman for pretending to greet a Belgian man with a hug and stealing 600 euros in cash (approximately 21,000 baht) from him in the Patong ...